Catalyst Wire Dossier Catalyst Wire Dossier

ACTOPLUS MET

pioglitazone and metformin hydrochloride · Takeda Pharmaceuticals America, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for ACTOPLUS MET, covering 2006-08-30 to 2026-08-11. Get the full timeline:

Most recent: FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

See pricing